Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review

Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review

Abstract Background While denosumab has been shown to prevent skeletal-related events in patients with bone metastasis, there is a concern that it may cause atypical femoral fracture (AFF). While AFF has been reported in patients with osteoporosis receiving denosumab, data are scarce in the context...

Full description

Bibliographic Details
Main Authors: Momoko Takahashi, Yukinori Ozaki, Rika Kizawa, Jun Masuda, Kentaro Sakamaki, Keiichi Kinowaki, Taro Umezu, Chihiro Kondoh, Yuko Tanabe, Nobuko Tamura, Yuji Miura, Takashi Shigekawa, Hidetaka Kawabata, Noriyuki Baba, Haruo Iguchi, Toshimi Takano
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Cancer
Subjects:
Femoral fractures
Denosumab
Bone metastasis
Retrospective studiess
Systematic review
Online Access:http://link.springer.com/article/10.1186/s12885-019-6236-6

Internet

http://link.springer.com/article/10.1186/s12885-019-6236-6

Similar Items